ADRENALS
adrenal, penis, testis, and scrotum. J Trauma 1996;41: 523–524.
6.Ferrozzi F, Cademartiri F, Tognini G. [Adrenal hydatidosis. The computed tomographic picture in a case.] [Review] [Italian] Radiol Med 1999;98:430–431.
7.Hahn ST, Park SH, Kim CY, Shinn KS. Adrenal paragonimiasis simulating adrenal tumor—a case report. J Korean Med Sci 1996;11:275–277.
8.Wang LJ, Wong YC, Chen CJ, Chu SH. Imaging spectrum of adrenal pseudocysts on CT. Eur Radiol 2003;13:531–535.
9.Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998;83:55–62.
10.Honigschnabl S, Gallo S, Niederle B, et al. How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 2002; 41:113–122.
11.Cataldi A, Cortese G, Corradino R, Porpiglia F, Ali A, Fava C. [Characterization of non-secreting adrenal nodules (incidentalomas): role of multiphasic spiral computerized tomography.] [Italian] Radiol Med 2000;100:257–261.
12.Namimoto T, Yamashita Y, Mitsuzaki K, et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology 2001;218:642–646.
13.Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S. Char-
acterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR 2003;180: 1649–1657.
14.Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR 2004;183:215–219.
15.Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998;207:369–375.
16.Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrastenhanced CT. Radiology 2000;217:798–802.
17.Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR 2000;175:1411–1415.
18.Chung JJ, Semelka RC, Martin DR. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging 2001;13: 242–248.
19.Hofle G, Gasser RW, Lhotta K, Janetschek G, Kreczy A, Finkenstedt G. Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing’s syndrome in an adrenal incidentaloma. A case report. Horm Res 1998;50:237–242.
20.Joual A, Patard JJ, Chopin D, Abbou CC. [Contralateral aneurysm-like adrenal gland metastasis of a renal adenocarcinoma.] [French] Prog Urol 1998;8:89–91.
21.Tsukamoto E, Itoh K, Kanegae K, Kobayashi S, Koyanagi T, Tamaki N. Accumulation of iodine- 131–iodocholesterol in renal cell carcinoma adrenal metastases. J Nucl Med 1998;39:656–658.
22.Shibata T, Maetani Y, Ametani F, Itoh K, Konishi J. Percutaneous ethanol injection for treatment of adrenal
metastasis from hepatocellular carcinoma. AJR 2000; 174:333–335.
23.Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CTguided radiofrequency ablation–preliminary results. Radiology 2004;231:225–230.
24Sohaib SA, Hanson JA, Newell-Price JD, et al. CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing’s syndrome. AJR 1999; 172:997–1002.
25.Midorikawa S, Hashimoto S, Kuriki M, et al. A patient with preclinical Cushing’s syndrome and excessive DHEA-S secretion having unilateral adrenal carcinoma and contralateral adenoma. Endocr J 1999;46: 59–66.
26.Otsuka F, Ogura T, Nakao K, et al. Cushing’s syndrome due to unilateral adrenocortical hyperplasia. Intern Med 1998;37:385–390.
27.Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR, Nieman LK. Adrenocorticotropinindependent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism. Radiology 2000;216:797–802.
28.Stewart PM. Mineralocorticoid hypertension. [Review] Lancet 1999;353:1341–1347.
29.Lingam RK, Sohaib SA, Vlahos I, et al. CT of primary
hyperaldosteronism (Conn’s syndrome): the value of measuring the adrenal gland. AJR 2003;181:843– 849.
30.Lorenzo Romero JG, Salinas Sanchez AS, Segura Martin M, et al. [The Conn syndrome. The clinical and surgical aspects of 18 cases of adrenal adenoma.] [Spanish] Actas Urol Esp 1999;23:14–21.
31.Sohaib SA, Peppercorn PD,Allan C, et al. Primary hyperaldosteronism (Conn syndrome): MR imaging findings. Radiology 2000;214:527–531.
32.Liang HL, Pan HB, Lee YH, et al. Small functional adrenal cortical adenoma: treatment with CT-guided percutaneous acetic acid injection–report of three cases. Radiology 1999;213:612–615.
33.Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 1999;340:1872–1879.
34.Jalil ND, Pattou FN, Combemale F, et al. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg 1998;164:23– 28.
35.Blake MA, Krishnamoorthy SK, Boland GW, et al. Lowdensity pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR 2003;181:1663–1668.
36.Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2– [fluorine-18]fluoro-2-deoxy-D-glucose PET Radiology 1999;212:35–41.
37.Trampal C, Engler H, Juhlin C, Bergstrom M, Langstrom B. Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 2004;230:423–428.
38.Slapa RZ, Jakubowski W, Kasperlik-Zaluska AA, et al. Adrenal ganglioneuroblastoma in pregnant woman: diagnosis with three-dimensional ultrasound. Eur Radiol 2002;12 Suppl 3:S121–126.